Interferon-γ-inducing factor (IL-18) and interferon-γ in inflammatory CNS diseases

OBJECTIVE: To examine the intrathecal production of a newly identified cytokine, interferon-gamma-inducing factor (IL-18), together with interferon-gamma itself, in inflammatory diseases of the CNS (i.e., bacterial meningitis, viral meningoencephalitis, and MS). - RESULTS: IL-18 concentrations in CS...

Full description

Saved in:
Bibliographic Details
Main Authors: Faßbender, Klaus (Author) , Mielke, Orell (Author) , Bertsch, Thomas (Author) , Muehlhauser, F. (Author) , Hennerici, Michael G. (Author) , Kurimoto, M. (Author) , Rossol, Siegbert (Author)
Format: Article (Journal)
Language:English
Published: September 1, 1999
In: Neurology
Year: 1999, Volume: 53, Issue: 5, Pages: 1104-1106
ISSN:1526-632X
DOI:10.1212/wnl.53.5.1104
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1212/wnl.53.5.1104
Get full text
Author Notes:K. Fassbender, O. Mielke, T. Bertsch, F. Muehlhauser, M. Hennerici, M. Kurimoto, and S. Rossol
Description
Summary:OBJECTIVE: To examine the intrathecal production of a newly identified cytokine, interferon-gamma-inducing factor (IL-18), together with interferon-gamma itself, in inflammatory diseases of the CNS (i.e., bacterial meningitis, viral meningoencephalitis, and MS). - RESULTS: IL-18 concentrations in CSF were significantly increased in bacterial meningitis and tended toward increased levels in viral meningoencephalitis. In contrast, IL-18 was detectable only in a few patients with MS and healthy controls. Interestingly, interferon-gamma was significantly increased selectively in CSF of patients with viral meningoencephalitis. - CONCLUSION: The observation of an intrathecal release of IL-18 in patients with meningitis argues for a pathophysiologic role of this novel cytokine in immunity against invading microorganisms the CNS.
Item Description:Gesehen am 27.07.2022
Physical Description:Online Resource
ISSN:1526-632X
DOI:10.1212/wnl.53.5.1104